Last reviewed · How we verify
Blood and milk samples
At a glance
| Generic name | Blood and milk samples |
|---|---|
| Sponsor | University Hospital, Toulouse |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms (PHASE2)
- Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance (NA)
- Iron Deficiency (ID) in Infants (NA)
- Pilot Study-Quantitative Analysis of Positional Fatty Acids in Postprandial Chylomicron Triacylglycerol Using 13C NMR Spectroscopy (NA)
- Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer (NA)
- Bone and Inflammatory Outcomes - Nutrition and Exercise Trials (NA)
- Maternal Characteristics Associated With Child Growth and Adiposity
- Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood and milk samples CI brief — competitive landscape report
- Blood and milk samples updates RSS · CI watch RSS
- University Hospital, Toulouse portfolio CI